Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Published 2017 View Full Article

Authors

Keywords

Plasmalogen, Scallop, Alzheimer's disease, Mild cognitive impairment, Cognitive function

Journal

EBioMedicine

Volume 17, Issue -, Pages 199-205

Publisher

Elsevier BV

Online

2017-02-25

DOI

10.1016/j.ebiom.2017.02.012

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started